- Home
- MAIA vs SRTS Comparison
MAIA vs SRTS Comparison
Compare MAIA & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- SRTS
- Stock Information
- Founded
- MAIA 2018
- SRTS 2010
- Country
- MAIA United States
- SRTS United States
- Employees
- MAIA N/A
- SRTS N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- SRTS Medical/Dental Instruments
- Sector
- MAIA Health Care
- SRTS Health Care
- Exchange
- MAIA Nasdaq
- SRTS Nasdaq
- Market Cap
- MAIA 56.3M
- SRTS 51.8M
- IPO Year
- MAIA 2022
- SRTS 2016
- Fundamental
- Price
- MAIA $1.84
- SRTS $3.57
- Analyst Decision
- MAIA
- SRTS Strong Buy
- Analyst Count
- MAIA 0
- SRTS 3
- Target Price
- MAIA N/A
- SRTS $8.00
- AVG Volume (30 Days)
- MAIA 636.1K
- SRTS 90.5K
- Earning Date
- MAIA 11-11-2025
- SRTS 11-13-2025
- Dividend Yield
- MAIA N/A
- SRTS N/A
- EPS Growth
- MAIA N/A
- SRTS N/A
- EPS
- MAIA N/A
- SRTS N/A
- Revenue
- MAIA N/A
- SRTS $37,564,000.00
- Revenue This Year
- MAIA N/A
- SRTS N/A
- Revenue Next Year
- MAIA N/A
- SRTS $46.14
- P/E Ratio
- MAIA N/A
- SRTS N/A
- Revenue Growth
- MAIA N/A
- SRTS 3.29
- 52 Week Low
- MAIA $1.40
- SRTS $3.03
- 52 Week High
- MAIA $3.48
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- MAIA 64.38
- SRTS 57.80
- Support Level
- MAIA $1.65
- SRTS $3.11
- Resistance Level
- MAIA $1.88
- SRTS $3.24
- Average True Range (ATR)
- MAIA 0.09
- SRTS 0.12
- MACD
- MAIA 0.03
- SRTS 0.08
- Stochastic Oscillator
- MAIA 73.33
- SRTS 76.85
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.